Getinge AB (publ) (OTCMKTS:GNGBY) Is experiencing a large decline in short interest

Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report ) received a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 9,900 shares, down 12.4% from its August 31st total of 11,300 shares. Based on an average daily trading volume of 23,700 shares, the short interest rate is currently 0.4 days.

Getinge AB (publ) stocks rose by 0.2%

Shares of GNGBY traded up $0.05 during trading hours on Monday, reaching $21.48. The company had a trading volume of 8,867 shares, compared to its average volume of 12,463. Getinge AB has a 12-month low of $16.71 and a 12-month high of $22.85. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.67, and a quick ratio of 0.98. The company has a market cap of $5.85 billion, a price-to-earnings ratio of 27.19 and a beta of 0.82. The company has a fifty day simple moving average of $20.37 and a 200 day simple moving average of $19.38.

Getinge AB (publ) (OTCMKTS:GNGBY – Get Your Free Report ) last posted its quarterly earnings results on Thursday, July 18th. The company reported $0.21 EPS for the quarter. Getinge AB (publ) had a net margin of 7.76% and a return on equity of 8.56%. The company had revenue of $776.85 million for the quarter.

About Getinge AB (publ)

(Get a free report)

Getinge AB (publ) offers products and solutions for operating rooms, intensive care units and sterilization departments. The company operates through the Acute Care Therapies, Life Science and Surgical Workflows segments. Provides extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, critical care infrastructure equipment, patient flow management and drainage solutions.

Recommended articles

Get news and ratings for Getinge AB (publ) daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Getinge AB (publ) and related companies with MarketBeat.com’s FREE daily email newsletter.